Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$174 Mln
P/E Ratio
--
P/B Ratio
28.57
Industry P/E
--
Debt to Equity
0.53
ROE
-1.44 %
ROCE
-122.46 %
Div. Yield
0 %
Book Value
0.13
EPS
-0.28
CFO
$-54.03 Mln
EBITDA
$-93.95 Mln
Net Profit
$-82.60 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Stereotaxis (STXS)
| -4.39 | 36.25 | -10.29 | 0.93 | 0.00 | -11.03 | 2.11 |
|
BSE Sensex
| 1.54 | 7.04 | 2.05 | 8.15 | 13.16 | 20.22 | 11.35 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Stereotaxis (STXS)
| 30.01 | -15.46 | -66.61 | 21.81 | -3.78 | 389.36 | 34.90 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 55.56 | 9,890.59 | 94 | 2.52 | |
| 56.43 | 11,750.62 | 22.16 | 11.42 | |
| 156.70 | 8,800.17 | -- | -25.23 | |
| 302.17 | 11,462.87 | 276.64 | 3.65 |
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such... as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri. Address: 710 North Tucker Boulevard, Saint Louis, MO, United States, 63101 Read more
CEO & Chairman
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
CEO & Chairman
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
Headquarters
Saint Louis, MO
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Stereotaxis Inc (STXS) stood at $ 47 Mln as on 31-Dec-24
The share price of Stereotaxis Inc (STXS) is $2.18 (NYSE) as of 09-May-2025 10:36 EDT. Stereotaxis Inc (STXS) has given a return of 0% in the last 3 years.
Stereotaxis Inc (STXS) has a market capitalisation of $ 174 Mln as on 08-May-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Stereotaxis Inc (STXS) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Stereotaxis Inc (STXS) and enter the required number of quantities and click on buy to purchase the shares of Stereotaxis Inc (STXS).
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri. Address: 710 North Tucker Boulevard, Saint Louis, MO, United States, 63101
The CEO & director of Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.. is Stereotaxis Inc (STXS), and CFO & Sr. VP is Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A..
There is no promoter pledging in Stereotaxis Inc (STXS).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,175
|
|
|
1,146
|
|
|
989
|
|
|
880
|
| Stereotaxis Inc. (STXS) | Ratios |
|---|---|
|
Return on equity(%)
|
-173.14
|
|
Operating margin(%)
|
-91.91
|
|
Net Margin(%)
|
-89.33
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Stereotaxis Inc (STXS) was $0 Mln.
$0.02
(
